Manulife (Manufacturers Life Insurance)’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.58M | Sell |
5,308
-3,538
| -40% | -$1.15M | ﹤0.01% | 1598 |
|
|
2025
Q4 | $2.7M | Sell |
8,846
-4,732
| -35% | -$1.55M | ﹤0.01% | 1408 |
|
|
2025
Q3 | $4.63M | Buy |
13,578
+11,566
| +575% | +$3.51M | ﹤0.01% | 1208 |
|
|
2025
Q2 | $487K | Sell |
2,012
-54,236
| -96% | -$13.3M | ﹤0.01% | 2188 |
|
|
2025
Q1 | $15.3M | Sell |
56,248
-3,583
| -6% | -$838K | 0.01% | 682 |
|
|
2024
Q4 | $11.1M | Buy |
59,831
+2,447
| +4% | +$500K | 0.01% | 837 |
|
|
2024
Q3 | $12.9M | Buy |
57,384
+7,122
| +14% | +$1.28M | 0.01% | 776 |
|
|
2024
Q2 | $7.17M | Buy |
50,262
+3,915
| +8% | +$603K | 0.01% | 984 |
|
|
2024
Q1 | $7.25M | Buy |
46,347
+6,588
| +17% | +$1.06M | 0.01% | 1017 |
|
|
2023
Q4 | $7.17M | Buy |
39,759
+5,304
| +15% | +$960K | ﹤0.01% | 1000 |
|
|
2023
Q3 | $6.2M | Buy |
34,455
+932
| +3% | +$184K | ﹤0.01% | 1015 |
|
|
2023
Q2 | $5.98M | Buy |
33,523
+11,268
| +51% | +$2.59M | ﹤0.01% | 995 |
|
|
2023
Q1 | $4.8M | Buy |
22,255
+3,547
| +19% | +$851K | ﹤0.01% | 1098 |
|
|
2022
Q4 | $4.15M | Sell |
18,708
-889
| -5% | -$163K | ﹤0.01% | 1151 |
|
|
2022
Q3 | $2.66M | Sell |
19,597
-1,500
| -7% | -$258K | ﹤0.01% | 1307 |
|
|
2022
Q2 | $3.42M | Buy |
21,097
+922
| +5% | +$144K | ﹤0.01% | 1270 |
|
|
2022
Q1 | $4.01M | Buy |
20,175
+12,275
| +155% | +$2.61M | ﹤0.01% | 1297 |
|
|
2021
Q4 | $2.15K | Sell |
7,900
-400
| -5% | -$135K | ﹤0.01% | 1472 |
|
|
2021
Q3 | $3.01M | Buy |
8,300
+800
| +11% | +$262K | ﹤0.01% | 1394 |
|
|
2021
Q2 | $2.57M | Sell |
7,500
-100
| -1% | -$33.1K | ﹤0.01% | 1505 |
|
|
2021
Q1 | $2.65M | Sell |
7,600
-700
| -8% | -$232K | ﹤0.01% | 1463 |
|
|
2020
Q4 | $2.15M | Sell |
8,300
-6,678
| -45% | -$1.84M | ﹤0.01% | 1508 |
|
|
2020
Q3 | $4.29M | Sell |
14,978
-5,322
| -26% | -$1.25M | ﹤0.01% | 1171 |
|
|
2020
Q2 | $3.84M | Buy |
20,300
+5,400
| +36% | +$879K | ﹤0.01% | 1205 |
|
|
2020
Q1 | $1.83M | Sell |
14,900
-130,316
| -90% | -$20.4M | ﹤0.01% | 1323 |
|
|
2019
Q4 | $24.1M | Sell |
145,216
-80,786
| -36% | -$13.4M | 0.03% | 503 |
|
|
2019
Q3 | $27.5M | Sell |
226,002
-9,172
| -4% | -$1.22M | 0.03% | 462 |
|
|
2019
Q2 | $29.1M | Buy |
235,174
+170,412
| +263% | +$21.6M | 0.03% | 442 |
|
|
2019
Q1 | $8.55M | Sell |
64,762
-11,925
| -16% | -$1.61M | 0.01% | 947 |
|
|
2018
Q4 | $10.8M | Buy |
76,687
+7,927
| +12% | +$1.05M | 0.01% | 745 |
|
|
2018
Q3 | $11.8M | Sell |
68,760
-38,515
| -36% | -$6.48M | 0.01% | 780 |
|
|
2018
Q2 | $16.5M | Buy |
107,275
+42,936
| +67% | +$7.66M | 0.02% | 656 |
|
|
2018
Q1 | $10.8M | Sell |
64,339
-21,094
| -25% | -$2.86M | 0.01% | 838 |
|
|
2017
Q4 | $8.35M | Sell |
85,433
-9,500
| -10% | -$870K | 0.01% | 970 |
|
|
2017
Q3 | $9.82M | Hold |
94,933
| – | – | 0.01% | 825 |
|
|
2017
Q2 | $4.27M | Buy |
94,933
+2,300
| +2% | +$90.6K | 0.01% | 1237 |
|
|
2017
Q1 | $3.39M | Buy |
92,633
+45,326
| +96% | +$1.65M | ﹤0.01% | 1283 |
|
|
2016
Q4 | $1.44M | Hold |
47,307
| – | – | ﹤0.01% | 1500 |
|
|
2016
Q3 | $1.46M | Hold |
47,307
| – | – | ﹤0.01% | 1467 |
|
|
2016
Q2 | $1.41M | Sell |
47,307
-71,969
| -60% | -$2.11M | ﹤0.01% | 1450 |
|
|
2016
Q1 | $3.41M | Buy |
+119,276
| New | +$3.38M | ﹤0.01% | 1229 |
|
Other funds holding ONC
BBA
HA
Manulife (Manufacturers Life Insurance)'s ONC Position: Q1 2026 in Review
Manulife (Manufacturers Life Insurance) reduced its BeOne Medicines Ltd (ONC) stake by 40% in Q1 2026, selling an estimated $1.15M and leaving 5,308 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1598.
Manulife (Manufacturers Life Insurance) first reported a position in ONC in Q1 2016 and has held it in 41 quarters since. The position peaked at $29.1M in Q2 2019. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.
- Manulife (Manufacturers Life Insurance) held 5,308 shares of BeOne Medicines Ltd worth $1.58M as of Q1 2026.
- Manulife (Manufacturers Life Insurance) sold 3,538 BeOne Medicines Ltd shares in Q1 2026, an estimated $1.15M.
- BeOne Medicines Ltd made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1598 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in BeOne Medicines Ltd in Q1 2016 and has held it in 41 quarters since.
- Manulife (Manufacturers Life Insurance)'s BeOne Medicines Ltd position peaked at $29.1M in Q2 2019.
- 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.